Skip to main content
. 2019 Jul 29;10(5):1893–1907. doi: 10.1007/s13300-019-0671-x

Table 2.

Statements that did not achieve consensus in the Delphi study

graphic file with name 13300_2019_671_Tab2a_HTML.jpg

graphic file with name 13300_2019_671_Tab2b_HTML.jpg

S statement, BMI body mass index, SGLT2-I sodium/glucose cotransporter-2 inhibitor, GLP1-RA glucagon-like peptide-1 receptor agonist, CV cardiovascular, CVD cardiovascular disease, NAFLD non-alcoholic fatty liver disease, T2D type 2 diabetes, HBA1c glycated hemoglobin, DPP4-I dipeptidyl peptidase-4 inhibitor, eGFR estimated glomerular filtration rate, SU sulfonylurea, C consensus, NC non-consensus, A agreement, D disagreement, I indeterminate

Clear grey font: First round results

Black font: Second round results

Italics: Statements reworded for the second round

*According to the order in which the statements were presented in the Delphi questionnaire

**Close to the limit of achieving consensus (66.6%)